17
Views
3
CrossRef citations to date
0
Altmetric
Main Article

Trimethoprim and Methenamine Hippurate: A New Theoretical Combination for the Treatment of Urinary Tract Infections

, , &
Pages 211-218 | Published online: 02 Jan 2015

References

  • . Amyes SGB, Emmerson AM, Smith JT. R-factor mediated trimethoprim resistance: result of two three-month clinical surveys. J Clin Pathol 31: 850, 1978.
  • . Baethke R, Golde G, Gahl G. Sulphamethoxazole/trimethoprim: Pharmacokinetic studies in patients with chronic renal failure. Eur J Clin Pharmacol 4: 233, 1972.
  • . Brendel R. Untersuchungen an Ratten zur Verträglichkeit von Hexamethylentetramin. Arzneim Forsch 14: 51, 1964.
  • . Bushby SRM. Trimethoprim and sulphonamides: Laboratory studies. South Afr Med J 44, Suppl. 15: 3, 1970.
  • . Craig WA, Kunin CM. Trimethoprim-sulfamethoxazole-pharmacodynamic effects of urinary pH and impaired renal function. Studies in humans. Ann Intern Med 78: 491, 1973.
  • . Della Porta G, Colnoghi MI, Parmiani G. Non-carcinogenicity of hexamethylenetetramine in mice and rats. Food Cosmet Toxicol 6: 707, 1968.
  • . Della Porta G, Gabral JR, Parmiani G. Studio della tossicita transplacentare e di cancerogenesi in ratti trattati con esametilentetramina. Tumori 56: 325, 1970.
  • . Edmunds PN. Synergy between sulphonamide and trimethoprim in the presence of pus. J Clin Pathol 31: 162, 1978.
  • . Farrar WE. Trimethoprim-sulfamethoxazole. Antimicrobial synergism. Am Fam Physician 10: 112, 1974.
  • . Gandelman AL. Methenamine mandelate: Antimicrobial activity in urine and correlation with formaldehyde levels. J Urol 97: 533, 1967.
  • . Garrod LP, Waterworth PM. Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin. J Clin Pathol 22: 534, 1969.
  • . Greenwood D, O'Grady F. Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli. J Clin Pathol 29: 162, 1976.
  • . Hamilton-Miller JMT, Brumfitt W. Methenamine and its salts as urinary tract antiseptics. Variables affecting the antibacterial activity of formaldehyde, mandelic acid, and hippuric acid in vitro. Invest Urol 14: 287, 1977.
  • . Jackson J, Stamey TA. The riker method for determining formaldehyde in the presence of methenamine. Invest Urol 9: 124, 1971.
  • . Kasanen A, Mustakallio E, Koskinen EH, Soini V. Methenamine hippurate in the treatment of urinary tract infections. Ann Clin Res 6: 279, 1974.
  • . Lacey RW, Lewis EL, Anderson JD. Further thoughts on sulphonamide-trimethoprim mixtures. J Clin Pathol 27: 512, 1973.
  • . Männistö PT, Lähteenmäki P. Comparison of sulfadiazine-trimethoprim and amoxycillin in the treatment of acute urinary tract infection. Curr Ther Res 23: 562, 1978.
  • . Schwartz DE, Koechlin BA, Weinfeld RE. Spectrofluorimetric method for the determination of trimethoprim in body fluids. Chemotherapy Suppl. 14: 22, 1969.
  • . Seneca H, Peer P. Clinical pharmacology and antibacterial action of methenamine and its salts. Med Times 97: 243, 1969.
  • . Seppänen J, Sulkava T, Vaalasti T, Korhonen H, Räisänen S, Ylitalo P. Combination of trimethoprim and methenamine hippurate in the treatment of acute urinary tract infections. Scand J Infect Dis 15: 201, 1983.
  • . Seppänen J, Ylitalo P, Julkunen R, Räisänen S, Masar S-E. Pharmacokinetics and clinical experiences of the combination sulfadiazine-trimethoprim in the short-term treatment of acute urinary tract infections. Ann Clin Res 12, Suppl. 25: 39, 1980.
  • . Sharpstone P. The renal handling of trimethoprim and sulfamethoxazole in man. Postgrad Med J 45, Suppl. 38, 1969.
  • . Stokes A, Lacey RW. Effect of thymidine inactivity of trimethoprim and sulphamethoxazole. J Clin Pathol 31: 165, 1978.
  • . Tuomisto J, Kasanen A, Renkonen O-V. Sulfadiazine-trimethoprim combination in the treatment of urinary tract infections. Chemotherapy 23: 337, 1977.
  • . Waterworth PM. A misapplication of the sensitivity test mandelamine discs. J Med Lab Technol 19: 163, 1962.
  • . Yodaiken RE. The uncertain consequences of formaldehyde toxicity. JAMA 246: 1677, 1981.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.